Oura closes $200M round, bringing its valuation to $5.2B
Oura obtains $200M funding, boosting its valuation to $5.2B.

Oura, a smart ring manufacturer, successfully acquired $200 million in a Series D funding round, resulting in a valuation boost to $5.2 billion. Notable participants in this latest round of funding include Fidelity Management and Dexcom, a glucose device maker. The support from these investors will drive Oura's momentum as it plans to expand its product offerings and focus on advancements in AI and other strategic areas.
A key development following this funding is the partnership between Oura and Dexcom, aimed at integrating their devices to help users monitor blood sugar while co-marketing their products. This collaboration is strengthened by Dexcom's $75 million investment in the Series D round. Oura emphasizes AI-driven strategies to realize its mission of making health a daily practice, and aims to create innovative opportunities beyond its smart rings.
Recently, Oura has experienced substantial growth, more than doubling its member base and revenue in one year, having sold over 2.5 million rings. The company also broadened its distribution channels by adding retail options like Amazon and Target and collaborating with entities such as the Naval Health Research Center. Additionally, Oura made acquisitions, including Sparta Science in October and Veri in September, which reflect its continued expansion and enhancement of its technology portfolio.